The compound heterozygosity for CYP2C9 ∗1/∗3 and CYP2D6 ∗1/∗4 differentiated MCS and SMCS cases from FM/CFS ones. Here, CYP2C9 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.